Gut microbiota can influence human brain function and behavior. Recent studies showed that gut microbiota might play an important role in the pathogenesis of Alzheimer’s disease (AD).
Objective:
To investigate the composition of gut microbiota in AD patients and their association with cognitive function and neuropsychiatric symptoms (NPS).
Methods:
The fecal samples from 60 AD patients (30 with NPS and 30 without NPS) and 32 healthy control subjects (HC) were collected and analyzed by 16S ribosomal RNA sequencing. The functional variations of gut microbiota were predicted using Phylogenetic Investigation of Communities by Reconstruction of Unobserved States. The correlation between different bacterial taxa and cognitive (Mini-Mental State Examination (MMSE), Clinical Dementia Rating (CDR)), and NPS measures were analyzed.
Results:
The fecal microbial composition of AD patients was quite distinct from HC. Bifidobacterium, Sphingomonas, Lactobacillus, and Blautia were enriched, while Odoribacter, Anaerobacterium, and Papillibacter were reduced. AD patients with NPS showed decreased Chitinophagaceae, Taibaiella, and Anaerobacterium compared with those without NPS. Functional pathways were different between AD and HC, and between AD patients with and without NPS. Correlation analysis showed that Sphingomonas correlated negatively with MMSE; Anaerobacterium and Papillibacter correlated positively with MMSE and negatively with CDR. Cytophagia, Rhodospirillaceae, and Cellvibrio correlated positively with NPS, while Chitinophagaceae, Taibaiella, and Anaerobacterium correlated negatively with NPS.
Conclusion:
AD patients have gut microbiota alterations related to cognition, and differential taxa between AD patients with and without NPS associated differently with NPS domains, which helps further understand the pathogenesis of AD and explore potential therapeutic targets.
McKhannGM, KnopmanDS, ChertkowH, HymanBT, JackCRJr., KawasCH, KlunkWE, KoroshetzWJ, ManlyJJ, MayeuxR, MohsRC, MorrisJC, RossorMN, ScheltensP, CarrilloMC, ThiesB, WeintraubS, PhelpsCH (2011) The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement7, 263–269.
2.
KinneyJW, BemillerSM, MurtishawAS, LeisgangAM, SalazarAM, LambBT (2018) Inflammation as a central mechanism in Alzheimer’s disease. Alzheimers Dement (N Y)4, 575–590.
3.
SochockaM, Donskow-LysoniewskaK, DinizBS, KurpasD, BrzozowskaE, LeszekJ (2019) The gut microbio-me alterations and inflammation-driven pathogenesis of Alzheimer’s disease-a critical review. Mol Neurobiol56, 1841–1851.
ChengHY, NingMX, ChenDK, MaWT (2019) Interactions between the gut microbiota and the host innate immune response against pathogens. Front Immunol10, 607.
6.
LeyRE, PetersonDA, GordonJI (2006) Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell124, 837–848.
WangT, HuX, LiangS, LiW, WuX, WangL, JinF (2015) Lactobacillus fermentum NS9 restores the antibiotic induced physiological and psychological abnormalities in rats. Benef Microbes6, 707–717.
18.
LuoJ, WangT, LiangS, HuX, LiW, JinF (2014) Ingestion of Lactobacillus strain reduces anxiety and improves cognitive function in the hyperammonemia rat. Sci China Life Sci57, 327–335.
19.
MohleL, MatteiD, HeimesaatMM, BereswillS, FischerA, AlutisM, FrenchT, HambardzumyanD, MatzingerP, DunayIR, WolfSA (2016) Ly6C(hi) monocytes provide a link between antibiotic-induced changes in gut microbiota and adult hippocampal neurogenesis. Cell Rep15, 1945–1956.
20.
HarachT, MarungruangN, DuthilleulN, CheathamV, Mc CoyKD, FrisoniG, NeherJJ, FakF, JuckerM, LasserT, BolmontT (2017) Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota. Sci Rep7, 41802.
21.
ZhuangZQ, ShenLL, LiWW, FuX, ZengF, GuiL, LuY, CaiM, ZhuC, TanYL, ZhengP, LiHY, ZhuJ, ZhouHD, BuXL, WangYJ (2018) Gut microbiota is altered in patients with Alzheimer’s disease. J Alzheimers Dis63, 1337–1346.
22.
LiuP, WuL, PengG, HanY, TangR, GeJ, ZhangL, JiaL, YueS, ZhouK, LiL, LuoB, WangB (2019) Altered microbiomes distinguish Alzheimer’s disease from amnestic mild cognitive impairment and health in a Chinese cohort. Brain Behav Immun80, 633–643.
LiB, HeY, MaJ, HuangP, DuJ, CaoL, WangY, XiaoQ, TangH, ChenS (2019) Mild cognitive impairment has similar alterations as Alzheimer’s disease in gut microbiota. Alzheimers Dement15, 1357–1366.
25.
ScottKP, GratzSW, SheridanPO, FlintHJ, DuncanSH (2013) The influence of diet on the gut microbiota. Pharmacol Res69, 52–60.
26.
MueggeBD, KuczynskiJ, KnightsD, ClementeJC, GonzalezA, FontanaL, HenrissatB, KnightR, GordonJI (2011) Diet drives convergence in gut microbiome functions across mammalian phylogeny and within humans. Science332, 970–974.
27.
GomezA, PetrzelkovaKJ, BurnsMB, YeomanCJ, AmatoKR, VlckovaK, ModryD, ToddA, Jost RobinsonCA, RemisMJ, TorralbaMG, MortonE, UmanaJD, CarboneroF, GaskinsHR, NelsonKE, WilsonBA, StumpfRM, WhiteBA, LeighSR, BlekhmanR (2016) Gut microbiome of coexisting BaAka pygmies and bantu reflects gradients of traditional subsistence patterns. Cell Rep14, 2142–2153.
28.
TyakhtAV, KostryukovaES, PopenkoAS, BelenikinMS, PavlenkoAV, LarinAK, KarpovaIY, SeleznevaOV, SemashkoTA, OspanovaEA, BabenkoVV, MaevIV, CheremushkinSV, KucheryavyyYA, ShcherbakovPL, GrinevichVB, EfimovOI, SasEI, AbdulkhakovRA, AbdulkhakovSR, LyalyukovaEA, LivzanMA, VlassovVV, SagdeevRZ, TsukanovVV, OsipenkoMF, KozlovaIV, TkachevAV, SergienkoVI, AlexeevDG, GovorunVM (2013) Human gut microbiota community structures in urban and rural populations in Russia. Nat Commun4, 2469.
29.
SchnorrSL, CandelaM, RampelliS, CentanniM, ConsolandiC, BasagliaG, TurroniS, BiagiE, PeanoC, SevergniniM, FioriJ, GottiR, De BellisG, LuiselliD, BrigidiP, MabullaA, MarloweF, HenryAG, CrittendenAN (2014) Gut microbiome of the Hadza hunter-gatherers. Nat Commun5, 3654.
30.
GuptaVK, PaulS, DuttaC (2017) Geography, ethnicity or subsistence-specific variations in human microbiome composition and diversity. Front Microbiol8, 1162.
31.
ShinosakiK, NishikawaT, TakedaM (2000) Neurobiological basis of behavioral and psychological symptoms in dementia of the Alzheimer type. Psychiatry Clin Neurosci54, 611–620.
32.
ReisbergB, AuerSR, MonteiroIM (1996) Behavioral pathology in Alzheimer’s disease (BEHAVE-AD) rating scale. Int Psychogeriatr8(Suppl 3), 301–308; discussion 351-304.
33.
MignecoO, BenoitM, KoulibalyPM, DygaiI, BertogliatiC, DesvignesP, RobertPH, MalandainG, BussiereF, DarcourtJ (2001) Perfusion brain SPECT and statistical parametric mapping analysis indicate that apathy is a cingulate syndrome: A study in Alzheimer’s disease and nondemented patients. Neuroimage13, 896–902.
34.
MegaMS, LeeL, DinovID, MishkinF, TogaAW, CummingsJL (2000) Cerebral correlates of psychotic symptoms in Alzheimer’s disease. J Neurol Neurosurg Psychiatry69, 167–171.
35.
StaffRT, ShanksMF, MacintoshL, PestellSJ, GemmellHG, VenneriA (1999) Delusions in Alzheimer’s disease: Spet evidence of right hemispheric dysfunction. Cortex35, 549–560.
36.
ZubenkoGS, MoossyJ, MartinezAJ, RaoG, ClaassenD, RosenJ, KoppU (1991) Neuropathologic and neurochemical correlates of psychosis in primary dementia. Arch Neurol48, 619–624.
37.
PalmerAM, StratmannGC, ProcterAW, BowenDM (1988) Possible neurotransmitter basis of behavioral changes in Alzheimer’s disease. Ann Neurol23, 616–620.
38.
MingerSL, EsiriMM, McDonaldB, KeeneJ, CarterJ, HopeT, FrancisPT (2000) Cholinergic deficits contribute to behavioral disturbance in patients with dementia. Neurology55, 1460–1467.
39.
KhachaturianZS (2011) Revised criteria for diagnosis of Alzheimer’s disease: National Institute on Aging-Alzh-eimer’s Association diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement7, 253–256.
40.
CummingsJL (1997) The Neuropsychiatric Inventory: Assessing psychopathology in dementia patients. Neurology48, S10–16.
MagocT, SalzbergSL (2011) FLASH: Fast length adjustment of short reads to improve genome assemblies. Bioinformatics27, 2957–2963.
43.
LiH, LiT, BerasateguiA, RuiJ, ZhangX, LiC, XiaoZ, LiX (2017) Gut region influences the diversity and interactions of bacterial communities in pikas (Ochotona curzoniae and Ochotona daurica). FEMS Microbiol Ecol93, doi: 10.1093/femsec/fix149
LiH, LiH, XieP, LiZ, YinY, BlachierF, KongX (2019) Dietary supplementation with fermented Mao-tai lees beneficially affects gut microbiota structure and function in pigs. AMB Express9, 26.
AroraT, SeyfriedF, DochertyNG, TremaroliV, le RouxCW, PerkinsR, BackhedF (2017) Diabetes-associated microbiota in fa/fa rats is modified by Roux-en-Y gastric bypass. ISME J11, 2035–2046.
48.
KarlssonFH, TremaroliV, NookaewI, BergstromG, BehreCJ, FagerbergB, NielsenJ, BackhedF (2013) Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature498, 99–103.
49.
ZengH, LiuJ, JacksonMI, ZhaoFQ, YanL, CombsGFJr. (2013) Fatty liver accompanies an increase in lactobacillus species in the hind gut of C57BL/6 mice fed a high-fat diet. J Nutr143, 627–631.
50.
HaGY, YangCH, KimH, ChongY (1999) Case of sepsis caused by Bifidobacterium longum. J Clin Microbiol37, 1227–1228.
51.
PoonamP, CherylT, AlwynR (2014) Bifidobacterium–friend or foe? A case of urinary tract infection with Bifidobacterium species. BMJ Case Rep2014, bcr201420–5122.
Gonzalez-NavajasJM, BellotP, FrancesR, ZapaterP, MunozC, Garcia-PaganJC, PascualS, Perez-MateoM, BoschJ, SuchJ (2008) Presence of bacterial-DNA in cirrhosis identifies a subgroup of patients with marked inflammatory response not related to endotoxin. J Hepatol48, 61–67.
TedelindS, WestbergF, KjerrulfM, VidalA (2007) Anti-inflammatory properties of the short-chain fatty acids acetate and propionate: A study with relevance to inflammatory bowel disease. World J Gastroenterol13, 2826–2832.
56.
ArpaiaN, CampbellC, FanX, DikiyS, van der VeekenJ, deRoosP, LiuH, CrossJR, PfefferK, CofferPJ, RudenskyAY (2013) Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature504, 451–455.
57.
ToralM, Robles-VeraI, de la VisitacionN, RomeroM, YangT, SanchezM, Gomez-GuzmanM, JimenezR, RaizadaMK, DuarteJ (2019) Critical role of the interaction gut microbiota - sympathetic nervous system in the regulation of blood pressure. Front Physiol10, 231.
58.
El BeainoM, FaresJ, MalekA, HachemR (2018) Sphingomonas paucimobilis-related bone and soft-tissue infections: A systematic review. Int J Infect Dis77, 68–73.
WilkoszPA, SeltmanHJ, DevlinB, WeamerEA, LopezOL, DeKoskyST, SweetRA (2010) Trajectories of cognitive decline in Alzheimer’s disease. Int Psychogeriatr22, 281–290.
61.
LiXL, HuN, TanMS, YuJT, TanL (2014) Behavioral and psychological symptoms in Alzheimer’s disease. Biomed Res Int2014, 927804.
62.
ZahodneLB, OrnsteinK, CosentinoS, DevanandDP, SternY (2015) Longitudinal relationships between Alzheimer disease progression and psychosis, depressed mood, and agitation/aggression. Am J Geriatr Psychiatry23, 130–140.
63.
PetersME, RosenbergPB, SteinbergM, NortonMC, Welsh-BohmerKA, HaydenKM, BreitnerJ, TschanzJT, LyketsosCG, Cache County Investigators (2013) Neuropsychiatric symptoms as risk factors for progression from CIND to dementia: The Cache County Study. Am J Geriatr Psychiatry21, 1116–1124.
64.
EeckhautV, Van ImmerseelF, TeirlynckE, PasmansF, FievezV, SnauwaertC, HaesebrouckF, DucatelleR, LouisP, VandammeP (2008) Butyricicoccus pullicaecorum gen. nov., sp. nov., an anaerobic, butyrate-producing bacterium isolated from the caecal content of a broiler chicken. Int J Syst Evol Microbiol58, 2799–2802.
YeJ, LvL, WuW, LiY, ShiD, FangD, GuoF, JiangH, YanR, YeW, LiL (2018) Butyrate protects mice against methionine-choline-deficient diet-induced non-alcoholic steatohepatitis by improving gut barrier function, attenuating inflammation and reducing endotoxin levels. Front Microbiol9, 1967.
67.
LahianiMH, GokulanK, WilliamsK, KhareS (2019) Impact of pristine graphene on intestinal microbiota assessed using a bioreactor-rotary cell culture system. ACS Appl Mater Interfaces11, 25708–25719.
68.
CollinsSM, SuretteM, BercikP (2012) The interplay between the intestinal microbiota and the brain. Nat Rev Microbiol10, 735–742.
69.
CryanJF, DinanTG (2012) Mind-altering microorganisms: The impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci13, 701–712.
70.
SampsonTR, MazmanianSK (2015) Control of brain development, function, and behavior by the microbiome. Cell Host Microbe17, 565–576.
71.
AgusA, PlanchaisJ, SokolH (2018) Gut microbiota regulation of tryptophan metabolism in health and disease. Cell Host Microbe23, 716–724.
72.
ZhangLS, DaviesSS (2016) Microbial metabolism of dietary components to bioactive metabolites: Opportunities for new therapeutic interventions. Genome Med8, 46.
73.
GolubevaAV, JoyceSA, MoloneyG, BurokasA, SherwinE, ArboleyaS, FlynnI, KhochanskiyD, Moya-PerezA, PetersonV, ReaK, MurphyK, MakarovaO, BuravkovS, HylandNP, StantonC, ClarkeG, GahanCGM, DinanTG, CryanJF (2017) Microbiota-related changes in bile acid & tryptophan metabolism are associated with gastrointestinal dysfunction in a mouse model of autism. EBioMedicine24, 166–178.
74.
LyteM, LiW, OpitzN, GaykemaRP, GoehlerLE (2006) Induction of anxiety-like behavior in mice during the initial stages of infection with the agent of murine colonic hyperplasia Citrobacter rodentium. Physiol Behav89, 350–357.
75.
GrayLR, TompkinsSC, TaylorEB (2014) Regulation of pyruvate metabolism and human disease. Cell Mol Life Sci71, 2577–2604.
